Seer Inc (SEER) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Seer Inc stock (SEER) is currently trading at $1.70. Seer Inc PS ratio (Price-to-Sales) is 5.72. Analyst consensus price target for SEER is $3.00. WallStSmart rates SEER as Sell.
- SEER PE ratio analysis and historical PE chart
- SEER PS ratio (Price-to-Sales) history and trend
- SEER intrinsic value — DCF, Graham Number, EPV models
- SEER stock price prediction 2025 2026 2027 2028 2029 2030
- SEER fair value vs current price
- SEER insider transactions and insider buying
- Is SEER undervalued or overvalued?
- Seer Inc financial analysis — revenue, earnings, cash flow
- SEER Piotroski F-Score and Altman Z-Score
- SEER analyst price target and Smart Rating
Seer Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Seer Inc (SEER) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book, institutional own.. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Seer Inc (SEER) Key Strengths (2)
Trading below book value, meaning the market prices it less than net assets
55.77% held by institutions, strong professional interest
Supporting Valuation Data
Seer Inc (SEER) Areas to Watch (5)
Company is destroying shareholder value
Losing money on operations
Micro-cap company with very limited liquidity and high volatility
Premium valuation at 5.7x annual revenue
Modest revenue growth at 5.00%
Supporting Valuation Data
Seer Inc (SEER) Detailed Analysis Report
Overall Assessment
This company scores 30/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 2 register as strengths (avg 9.0/10) while 5 fall into concern territory (avg 2.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book, Institutional Own.. Valuation metrics including Price/Book (0.37) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Market Cap. Some valuation metrics including Price/Sales (5.72) suggest expensive pricing. Growth concerns include Revenue Growth at 5.00%, which may limit upside. Profitability pressure is visible in Return on Equity at -25.10%, Operating Margin at -413.80%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -25.10% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 5.00% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SEER Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SEER's Price-to-Sales ratio of 5.72x trades at a deep discount to its historical average of 626.52x (1th percentile). The current valuation is 100% below its historical high of 5350.8x set in Jan 2021, and 0% above its historical low of 5.71x in Feb 2024. Over the past 12 months, the PS ratio has compressed from ~7.0x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Seer Inc (SEER) · HEALTHCARE › BIOTECHNOLOGY
The Big Picture
Seer Inc is in a high-growth phase, prioritizing rapid expansion over margins. Revenue reached 17M with 500% growth year-over-year. The company is currently unprofitable, posting a 0.0% profit margin.
Key Findings
Revenue growing at 500% YoY, reaching 17M. This pace significantly outperforms most BIOTECHNOLOGY peers.
Spending 59% of revenue (10M) on R&D, reinforcing its commitment to innovation and future growth.
Free cash flow is -11M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can Seer Inc maintain 500%+ revenue growth, or will competition slow it down?
Volatility is elevated with a beta of 1.66, so expect amplified moves relative to the broader market.
Sector dynamics: monitor BIOTECHNOLOGY industry trends, competitive moves, and regulatory changes that could impact Seer Inc.
Bottom Line
Seer Inc is a high-conviction growth story with revenue accelerating at 500% while profitability is still developing. For growth-oriented investors, the trajectory is compelling. For value investors, the thin 0.0% margins and premium valuation suggest patience until the unit economics mature further.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(6 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 8:25:19 AM
About Seer Inc(SEER)
NASDAQ
HEALTHCARE
BIOTECHNOLOGY
USA
Seer, Inc., a life sciences company, is dedicated to developing and marketing products for researchers to unlock biological information. The company is headquartered in Redwood City, California.